FDA Clarifies Oversight for Digital Tools Used in Stress Management and Mindful Movement

FDA Policy Distinguishes Regulated Devices From Low-Risk Wellness Tools for Stress and Activity

The FDA applies regulatory oversight to digital health technologies only when they meet the statutory definition of a medical device. Products intended solely for general wellness, such as apps and wearables that track physical activity or support stress management without disease claims, generally fall outside premarket review. The agency spelled out this risk-based line in multiple guidance documents. Its Digital Health Center of Excellence coordinates related policy and stakeholder input.

What this means

FDA policies draw a line between medical devices and consumer wellness products. Many activity trackers and stress apps reach the market without formal review when their labeling and promotion stay clear of specific disease claims. This shapes the digital tools available for daily movement and relaxation practices.

Key takeaways

• Intended use stated in labeling and marketing determines regulatory classification. [3]
• Low-risk general wellness devices for physical activity and stress management are not subject to FDA premarket review. [2]
• Simple fitness trackers and stress-relief apps without disease claims typically receive enforcement discretion. [3]
• A risk-based approach prioritizes higher-risk diagnostic or therapeutic claims for formal oversight. [3]
• The Digital Health Center of Excellence coordinates policy and stakeholder engagement on these technologies. [1]

Regulatory Threshold for Digital Health Technologies

The FDA regulates digital health technologies if they meet the statutory definition of a medical device under the Federal Food, Drug, and Cosmetic Act. [3] This happens when a product claims to diagnose, treat, mitigate, prevent or cure a specific disease or condition.

Stress management apps cross the line if they market themselves as treatments for clinical anxiety. Trackers that log heart-rate variability for general relaxation stay in the wellness category. The same distinction holds for tools that support mindful movement. [2][3]

General Wellness Policy Details

FDA policy from 2019 sets two conditions for general wellness classification. The product must aim to sustain or encourage a healthy lifestyle. It must also avoid any intent to diagnose or treat disease. [2]

Many wearables and apps satisfy both conditions. Their marketing language centers on physical activity or daily stress management. Such products skip premarket review. [2][3]

Software Functions in Mobile Applications

Guidance on device software functions identifies when the FDA applies enforcement discretion. Activity tracking features and basic stress monitors usually qualify for this discretion if they make no disease claims. [3]

The agency provided examples in its policy for mobile medical applications. Simple mindfulness timers or movement reminders rarely trigger active regulation. The boundary moves, however, when promotional materials imply the tool can treat a disorder or replace therapy. [3]

Role of the Digital Health Center of Excellence

The Digital Health Center of Excellence serves as a central hub for the FDA’s digital health activities. It coordinates regulatory policy on software as a medical device and promotes engagement with developers. [1]

The center also covers remote data acquisition for clinical investigations. This includes physiological signals linked to activity and stress. [4] Developers working on novel tools sometimes reach out to the center for feedback, yet most general wellness products need no formal interaction. [1]

Limitations

Guidance documents reflect current policy but remain subject to updates. They do not address every emerging AI or multimodal sensor use case. Clinical validation requirements for higher-risk claims receive mention yet are not detailed exhaustively. Public comment periods on draft policies can lead to revisions.

FAQ

When does a stress or physical activity monitoring app qualify as a regulated medical device?
It qualifies when the product’s intended use includes diagnosing, treating, mitigating, preventing or curing a specific disease or condition. [3]

What is the difference between general wellness use and medical use according to FDA policy?
General wellness use centers on sustaining or encouraging a healthy lifestyle without disease claims. Medical use involves explicit intent to diagnose or treat a disease. [2]

How do developers determine if their DHT requires FDA review or enforcement discretion?
They review the intended use described in labeling and marketing, then compare it against the examples and criteria listed in FDA guidance documents. [3]

What role does the Digital Health Center of Excellence play in these technologies?
It coordinates cross-cutting digital health activities, develops regulatory policy and engages stakeholders on software functions and remote monitoring tools. [1][4]

Last updated: August 24, 2026